A double-blind, randomized, placebo and active controlled, multicenter study to investigate efficacy and safety after oral administration of 2 and 3 mg ZK 283197, 1 mg 17ß-estradiol and placebo once daily for 8 weeks in postmenopausal women with hot flushes
- Registry ID
- EUCTR2007-001791-36
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Bayer Schering Pharma AG
- Start date
- 2007-09-05
- Completion date
- 2009-02-11
- Last update
- 2026-08-16
Conditions
- Vasomotor symptoms (hot flushes)
Summary
To investigate the influence of a 8-weeks multiple dose treatment with two oral doses of ZK 283197 in comparison to E2 and placebo on the reduction of moderate to severe hot flushes
Locations
- , , Germany
- , , Netherlands
- , , UK
View on source registry